missing translation for 'onlineSavingsMsg'
Learn More

MMAB Monoclonal Antibody (OTI3B8), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Brand:  Origene Technologies TA502167

Encompass_Preferred

 View more versions of this product

Product Code. 17516171

  • € 540.87 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

This gene encodes a protein that catalyzes the final step in the conversion of vitamin B(12) into adenosylcobalamin (AdoCbl), a vitamin B12-containing coenzyme for methylmalonyl-CoA mutase. Mutations in the gene are the cause of vitamin B12-dependent methylmalonic aciduria linked to the cblB complementation group.
Specifications

Specifications

MMAB
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Q96EY8
MMAB
Full length human recombit protein of human MMAB produced in HEK293T cell.
100 μL
Primary
Human
Antibody
IgG2a
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot
OTI3B8
Unconjugated
MMAB
ATR, CFAP23, cblB, cob
Mouse
Affinity Chromatography
RUO
326625
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.